QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)
QQQ   390.43 (+1.40%)
AAPL   194.27 (+1.01%)
MSFT   370.95 (+0.58%)
META   326.59 (+2.88%)
GOOGL   136.93 (+5.31%)
AMZN   146.88 (+1.63%)
TSLA   242.64 (+1.37%)
NVDA   465.96 (+2.40%)
NIO   7.50 (-3.23%)
BABA   72.31 (+1.15%)
AMD   128.37 (+9.89%)
T   17.09 (+0.89%)
F   10.82 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.72 (+2.85%)
GE   119.48 (-0.28%)
DIS   92.35 (+0.93%)
AMC   6.83 (+0.59%)
PFE   28.62 (-0.59%)
PYPL   58.48 (-1.76%)
XOM   98.42 (-0.70%)

Medicure Stock Price, News & Analysis (CVE:MPH)

C$1.40
-0.16 (-10.26%)
(As of 05:29 PM ET)
Compare
Today's Range
C$1.40
C$1.40
50-Day Range
C$1.42
C$1.80
52-Week Range
C$0.93
C$1.80
Volume
300 shs
Average Volume
7,225 shs
Market Capitalization
C$14.35 million
P/E Ratio
15.56
Dividend Yield
2.24%
Price Target
N/A

MPH stock logo

About Medicure Stock (CVE:MPH)

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

MPH Stock Price History

MPH Stock News Headlines

Bletchley - Weather warnings issued
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Lewes - Weather warnings issued
Shrewsbury - Weather warnings issued
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Kidlington - Weather warnings issued
S12 - Weather warnings issued
Holkham - Weather warnings issued
Eastleigh - Weather warnings issued
Guildford - Weather warnings issued
Whitstable - Weather warnings issued
Medicure Inc.
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/21/2023
Today
12/07/2023
Next Earnings (Estimated)
4/04/2024

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$1.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$22.94 million
Cash Flow
C$0.63 per share
Book Value
C$2.10 per share

Miscellaneous

Free Float
N/A
Market Cap
C$15.99 million
Optionable
Not Optionable
Beta
1.02
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Albert David Friesen Ph.D. (Age 76)
    Founder, CEO & Chairman of the board
    Comp: $237.6k
  • Dr. Neil Owens Ph.D.
    President & COO
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer
  • Dr. Reuben Saba Ph.D.
    Vice President of Scientific & Medical Affairs














MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed in 2023?

Medicure's stock was trading at C$1.01 at the beginning of the year. Since then, MPH stock has increased by 38.6% and is now trading at C$1.40.
View the best growth stocks for 2023 here
.

When is Medicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our MPH earnings forecast
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) posted its earnings results on Tuesday, November, 21st. The company reported $0.01 EPS for the quarter. The company had revenue of $5 million for the quarter. Medicure had a trailing twelve-month return on equity of 5.04% and a net margin of 4.71%.

What other stocks do shareholders of Medicure own?
How do I buy shares of Medicure?

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:MPH) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -